(Teleborsa) – The equipment for the reconditioning pulmonary ex-vivo (EVLP: Ex Vivo Lung Perfusion). The machine was donated by LIFC Lazio County Office, through the Bambino Gesù Onlus Foundation, thanks to the fundamental support of Third Pillar Foundation – International chaired by Prof. Avv. Emmanuele FM Emanuele. With the realization of the project “From life to quality of life”, The Officium association, which for years has supported research to improve the treatment of patients with Cystic Fibrosis, has set itself the goal of increasing the chances of transplantation for patients on the waiting list for lung transplantation.
The “reconditioning” technique was born in the 70s and provides, starting from the lungs of donors that do not meet the standard criteria of transplantation, a treatment of the organs, lasting about four hours, which restores the functionality of the lungs and makes them transplantable . EVLP has developed over the years and has recently also seen its application in the pediatric field where, together with lobar transplantation, it represents an important alternative to solve the problem of limited availability of organs for this type of patient.
The Prof. Avv. Emmanuele FM Emanuele, President of the Terzo Pilastro Foundation, commented: “I am really pleased to have contributed, together with Officium, the committee of the Italian Cystic Fibrosis League, and the Bambino Gesù Hospital, to this important and innovative project. Our commitment in the health sector represents an essential moral duty towards the community and has always seen us at the forefront, on the territory, in the delicate sectors of health and scientific research, as evidenced in particular, among the many other initiatives promoted, the Hospice for terminally ill and ALS patients and the Emanuele Village for Alzheimer’s patients, both totally free and which have not ceased to operate even during the health emergency. I am sure that the existing collaboration with the LIFC and the Bambino Gesù Hospital will also bear excellent results, allowing the improvement of the quality and life expectancy of patients who need lung transplantation “.
.
